Acute Effect on Satiety, Resting Energy Expenditure, Respiratory Quotient, Glucagon-Like Peptide-1, Free Fatty Acids, and Glycerol Following Consumption of a Combination of Bioactive Food Ingredients in Overweight Subjects

Journal of the American College of Nutrition

Volumn 32, Issue 1, 2013, Pages 41-49

  Rondanelli, Mariangela ^a   Opizzi, Annalisa ^a   Perna, Simone ^a   Faliva, Milena ^a   Solerte, Sebastiano Bruno ^a   Fioravanti, Marisa ^a   Klersy, Catherine ^b   Edda, Cava ^c   Maddalena, Paolini ^d   Luciano, Scavone ^d   Paola, Ceccarelli ^d   Emanuela, Castellaneta ^d   Claudia, Savina ^d   Donini, Lorenzo Maria ^c  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d Villa Delle Querce Clinical Rehabilitation Institute   (Italy)

Author keywords

capsaicin; carnitine; epigallocatechin gallate; resting energy expenditure; satiety; thermogenesis

Indexed keywords

FATTY ACID; GLUCAGON LIKE PEPTIDE 1; GLYCEROL; 1,3 BENZODIOXOLE DERIVATIVE; ALKALOID; AMIDE; CAPSAICIN; CARNITINE; CATECHIN; EPIGALLOCATECHIN GALLATE; PIPERIDINE DERIVATIVE; PIPERINE; PLANT EXTRACT; DRUG DERIVATIVE;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DUAL ENERGY X RAY ABSORPTIOMETRY; EVALUATION AND FOLLOW UP; FEMALE; FOOD INTAKE; HUMAN; MALE; MIDDLE AGED; OBESITY; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY QUOTIENT; RESTING ENERGY EXPENDITURE; SATIETY; THERMOGENESIS; ANALOGS AND DERIVATIVES; AREA UNDER THE CURVE; BASAL METABOLIC RATE; BLOOD; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; METABOLISM; PHYTOTHERAPY; PSYCHOPHYSIOLOGY; CONTROLLED CLINICAL TRIAL; DRUG EFFECT;

ADULT; ALKALOIDS; AREA UNDER CURVE; BASAL METABOLISM; BENZODIOXOLES; CAPSAICIN; CARNITINE; CATECHIN; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCAGON-LIKE PEPTIDE 1; GLYCEROL; HUMANS; MALE; MIDDLE AGED; OBESITY; PHYTOTHERAPY; PIPERIDINES; PLANT EXTRACTS; POLYUNSATURATED ALKAMIDES; SATIATION; SATIETY RESPONSE;

EID: 84893401158     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2013.767667     Document Type: Article

References (62)

1. Curbing the obesity epidemic. Lancet, 367: 1549. 2006.
2. Segal, K R and Gutin, B. 1983. Thermic effects of food and exercise in lean and obese women. Metabolism, 32: 581 - 589.
3. de Jonge, L and Bray, G A. 1997. The thermic effect of food and obesity: A critical review. Obes Res, 5: 622 - 631.
4. Finer, N. 1997. Present and future pharmacological approaches. Br Med Bull, 53: 409 - 432.
5. Kawada, T, Hagihara, K and Iwai, K. 1986. Effects of capsaicin on lipid metabolism in rats fed a high fat diet. J Nutr, 116: 1272 - 1278.
6. Hachiya, S, Kawabata, F, Ohnuki, K, Inoue, N, Yoneda, H, Yazawa, S and Fushiki, T. 2007. Effects of CH-19 Sweet, a non-pungent cultivar of red pepper, on sympathetic nervous activity, body temperature, heart rate, and blood pressure in humans. Biosci Biotechnol Biochem, 71: 671 - 676.
7. Kawabata, F, Inoue, N, Yazawa, S, Kawada, T, Inoue, K and Fushiki, T. 2006. Effects of CH-19 sweet, a non-pungent cultivar of red pepper, in decreasing the body weight and suppressing body fat accumulation by sympathetic nerve activation in humans. Biosci Biotechnol Biochem, 70: 2824 - 2835.
8. Ohnuki, K, Niwa, S, Maeda, S, Inoue, N, Yazawa, S and Fushiki, T. 2001. CH-19 Sweet, a non-pungent cultivar of red pepper, increased body temperature and oxygen consumption in humans. Biosci Biotechnol Biochem, 65: 2033 - 2036.
9. Yoshioka, M, St-Pierre, S, Suzuki, M and Tremblay, A. 1998. Effects of red pepper added to high-fat and high-carbohydrate meals on energy metabolism and substrate utilization in Japanese women. Br J Nutr, 80: 503 - 510.
10. Westerterp-Plantenga, M S, Smeets, A and Lejeune, M P. 2005. Sensory and gastrointestinal satiety effects of capsaicin on food intake. Int J Obes (Lond), 29: 682 - 688.
11. Ludy, M J and Mattes, R D. 2011. The effects of hedonically acceptable red pepper doses on thermogenesis and appetite. Physiol Behav, 102: 251 - 258.
12. Yoshioka, M, St-Pierre, S, Drapeau, V, Dionne, I, Doucet, E, Suzuki, M and Tremblay, A. 1999. Effects of red pepper on appetite and energy intake. Br J Nutr, 82: 115 - 123.
13. Shin, K O and Moritani, T. 2007. The combined effects of capsaicin, green tea extract and chicken essence tablets on human autonomic nervous system activity. J Nutr Sci Vitaminol (Tokyo), 53: 145 - 152.
14. Nagao, T, Komine, Y, Soga, S, Meguro, S, Hase, T, Tanaka, Y and Tokimitsu, I. 2005. Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men. Am J Clin Nutr, 81: 122 - 129.
15. Boschmenn, M and Thielecke, F. 2007. The effects of epigallocatechin-3-gallate on thermogenesis and fat oxidation in obese men: A pilot study. J Am Coll Nutr, 26: 389S - 395S.
16. Rains, T M, Agarwal, S and Maki, K C. 2011. Antiobesity effects of green tea catechins: a mechanistic review. J Nutr Biochem, 22: 1 - 7.
17. Kao, Y H, Hiipakka, R A and Liao, S. 2000. Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology, 141: 980 - 987.
18. Kao, Y H, Hiipakka, R A and Liao, S. 2000. Modulation of obesity by a green tea catechin. Am J Clin Nutr, 72: 1232 - 1234.
19. Chen, L, Lee, M J, Li, H and Yang, C S. 1997. Absorption, distribution, elimination of tea polyphenols in rats. Drug Metab Dispos, 25: 1045 - 1050.
20. Rondanelli, M, Opizzi, A, Solerte, S B, Trotti, R, Klersy, C and Cazzola, R. 2009. Administration of a dietary supplement (N-oleyl-phosphatidylethanolamine and epigallocatechin-3-gallate formula) enhances compliance with diet in healthy overweight subjects: A randomized controlled trial. Br J Nutr, 101: 457 - 464.
21. Dulloo, A G, Duret, C, Rohrer, D, Girardier, L, Mensi, N, Fathi, M, Chantre, P and Vandermander, J. 1999. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr, 70: 1040 - 1045.
22. Rumpler, W, Seale, J, Clevidence, B, Judd, J, Wiley, E, Yamamoto, S, Komatsu, T, Sawaki, T, Ishikura, Y and Hosoda, K. 2001. Oolong tea increases metabolic rate and fat oxidation in men. J Nutr, 131: 2848 - 2852.
23. Kuppusamy, U R and Das, N P. 1992. Effects of flavonoids on cyclic AMP phosphodiesterase and lipid mobilization in rat adipocytes. Biochem Pharmacol, 44: 1307 - 1315.
24. Mochizuki, M and Hasegawa, N. 2004. Effects of green tea catechin-induced lipolysis on cytosol glycerol content in differentiated 3T3-L1 cells. Phytother Res, 18: 945 - 946.
25. Shixian, Q, VanCrey, B, Shi, J, Kakuda, Y and Jiang, Y. 2006. Green tea extract thermogenesis-induced weight loss by epigallocatechin gallate inhibition of catechol-O-methyltransferase. J Med Food, 9: 451 - 458.
26. Girotti, C, Ginet, M, Demarne, F C, Lagarde, M and Géloën, A. 2005. Lipolytic activity of cirsimarin extracted from Microtea debilis. Planta Med, 71: 1170 - 1172.
27. Renold, A E and Cahill, G F. 1965. " Adipose tissue ". In Handbook of Physiology, 94 - 99. Washington, DC: American Physiological Society.
28. Spector, A A. 1975. Fatty acid binding to plasma albumin. Lipid Res, 16: 165 - 179.
29. Robidoux, J, Kumar, N, Daniel, K W, Moukdar, F, Cyr, M, Medvedev, A V and Collins, S. 2006. Maximal beta3-adrenergic regulation of lipolysis involves Src and epidermal growth factor receptor-dependent ERK1/2 activation. J Biol Chem, 281: 37794 - 37802.
30. Steinberg, D and Khoo, J C. 1977. Hormone-sensitive lipase of adipose tissue. Fed Proc, 36: 1986 - 1990.
31. Kolditz, C I and Langin, D. 2010. Adipose tissue lipolysis. Curr Opin Clin Nutr Metab Care, 13: 377 - 381.
32. Yamamoto, H, Kishi, T, Lee, C E, Choi, B J, Fang, H, Hollenberg, A N, Drucker, D J and Elmquist, J K. 2003. Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites. J Neurosci, 23: 2939 - 2946.
33. Hwa, J J, Ghibaudi, L, Williams, P, Witten, M B, Tedesco, R and Strader, C D. 1998. Differential effects of intracerebroventricular glucagon-like peptide-1 on feeding and energy expenditure regulation. Peptides, 19: 869 - 875.
34. Kerner, J and Hoppel, C. 2000. Fatty acid import into mitochondria. Biochim Biophys Acta, 1486: 1 - 17.
35. Center, S A, Harte, J, Watrous, D, Reynolds, A, Watson, T D, Markwell, P J, Millington, D S, Wood, P A, Yeager, A E and Erb, H N. 2000. The clinical and metabolic effects of rapid weight loss in obese pet cats and the influence of supplemental oral L-carnitine. J Vet Intern Med, 14: 598 - 608.
36. Muller, D M, Seim, H, Kiess, W, Loster, H and Richter, T. 2002. Effects of oral L-carnitine supplementation on in vivo long-chain fatty acid oxidation in healthy adults. Metabolism, 51: 1389 - 1391.
37. Brass, E P. 2000. Supplemental carnitine and exercise. Am J Clin Nutr, 72: 618S - 623S.
38. Lofgren, I E, Herron, K L, West, KL, Zern, T L, Brownbill, R A, Ilich, J Z, Koo, S I and Fernandez, M L. 2005. Weight loss favorably modifies anthropometrics and reverses the metabolic syndrome in premenopausal women. J Am Coll Nutr, 24: 486 - 493.
39. American Psychiatric Association. 1994. " Mood disorders ". In Diagnostic and Statistical Manual of Mental Disorders, 4th ed., 317 - 345. Washington, DC: American Psychiatric Association. American Psychiatric Association
40. Harris, J A and Benedict, F G. 1919. " Biometric study of basal metabolism in man ". Washington, DC: Carnegie Institute. Publication no. 279
41. Wurtman, J J, Brzezinski, A, Wurtman, R J and Laferrere, B. 1989. Effect of nutrient intake on premenstrual depression. Am J Obstet Gynecol, 161: 1228 - 1234.
42. Haber, G B, Heaton, K W, Murphy, D and Burroughs, L F. 1977. Depletion and disruption of dietary fibre. Effects on satiety, plasma-glucose, and serum-insulin. Lancet, 2: 679 - 682.
43. Compher, C, Frankenfield, D, Keim, N and Roth-Yousey, L. 2006. Best practice methods to apply to measurement of resting metabolic rate in adults: A systematic review. J Am Diet Assoc, 106: 881 - 903.
44. Weir, J B. 1949. New methods for calculating metabolic rate with especial references to protein metabolism. J Physiol, 109: 1 - 9.
45. Kamel, E G, McNeill, G and Van Wijk, M C. 2000. Usefulness of anthropometry and DXA in predicting intra-abdominal fat in obese men and women. Obes Res, 8: 36 - 42.
46. Frisancho, A R. 1984. New standards of weight and body composition by frame size and height for assessment of nutritional status of adults and the elderly. Am J Clin Nutr, 40: 808 - 819.
47. Rondanelli, M, Opizzi, A, Perna, S, Faliva, M, Solerte, S B, Fioravanti, M, Klersy, C, Cava, E, Paolini, M, Scavone, L, Ceccarelli, P, Castellaneta, E, Savina, C and Donini, L M. 2012 Dec 28. Improvement in insulin resistance and favourable changes in plasma inflammatory adipokines after weight loss associated with two months' consumption of a combination of bioactive food ingredients in overweight subjects. Endocrine, [Epub ahead of print]
48. Kim, M S, Lee, M S and Kown, D Y. 2011. Inflammation-mediated obesity and insulin resistance as targets for nutraceuticals. Ann N Y Acad Sci, 1229: 140 - 146.
49. Bas, M and Donmez, S. 2009. Self-efficacy and restrained eating in relation to weight loss among overweight men and women in Turkey. Appetite, 52: 209 - 216.
50. Westerterp-Plantenga, M S, Kempen, K P and Saris, W H. 1998. Determinants of weight maintenance in women after diet-induced weight reduction. J Obes Relat Metab Disord, 22: 1 - 6.
51. Drapeau, V, Provencher, V, Lemieux, S, Després, J P, Bouchard, C and Tremblay, A. 2003. Do 6-y changes in eating behaviors predict changes in body weight? Results from the Québec Family Study. Int J Obes Relat Metab Disord, 27: 808 - 814.
52. Chaput, J P, Drapeau, V, Hetherington, M, Lemieux, S, Provencher, V and Tremblay, A. 2005. Psychobiologic impact of a progressive weight loss program in obese men. Physiol Behav, 86: 224 - 232.
53. Chaput, J P, Drapeau, V, Hetherington, M, Lemieux, S, Provencher, V and Tremblay, A. 2007. Psychobiological effects observed in obese men experiencing body weight loss plateau. Depress Anxiety, 24: 518 - 521.
54. Mezey, E, Tóth, Z E, Cortright, DN, Arzubi, M K, Krause, J E, Elde, R, Guo, A, Blumberg, P M and Szallasi, A. 2000. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci USA, 97: 3655 - 3660.
55. Sugiura, T, Kasai, M, Katsuya, H and Mizumura, K. 2003. Thermal properties of acid-induced depolarization in cultured rat small primary afferent neurons. Neurosci Lett, 350: 109 - 112.
56. Eldershaw, T P, Colquhoun, E Q, Bennett, K L, Dora, K A and Clark, M G. 1994. Resiniferatoxin and piperine: Capsaicin-like stimulators of oxygen uptake in the perfused rat hindlimb. Life Sci, 55: 389 - 397.
57. Kreymann, B, Williams, G, Ghatei, M A and Bloom, S R. 1987. Glucagon-like peptide-1 7-36: A physiological incretin in man. Lancet, 5: 1300 - 1304.
58. Elliott, R M, Morgan, L M, Tredger, J A, Deacon, S, Wright, J and Marks, V. 1993. Glucagon-like peptide-1 (7-36) amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: Acute post-prandial and 24-h secretion patterns. J Endocrinol, 138: 159 - 166.
59. Flint, A, Raben, A, Astrup, A and Holst, J J. 1998. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest, 101: 515 - 520.
60. Gutzwiller, J P, Drewe, J, Göke, B, Schmidt, H, Rohrer, B, Lareida, J and Beglinger, C. 1999. Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2. Am J Physiol, 276: R1541 - R1544.
61. Dulloo, A G. 1998. Spicing fat for combustion. Br J Nutr, 80: 493 - 494.
62. Lairon, D, Lopez-Miranda, J and Williams, C. 2007. Methodology for studying postprandial lipid metabolism. Eur J Clin Nutr, 61: 1145 - 1161.